OOIR: Observatory of International Research

Papers

(The H4-Index of Cancer Epidemiology Biomarkers & Prevention is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Medical Care Costs Associated with Cancer Survivorship in the United States	281
The Evolving Epidemiology of Nasopharyngeal Carcinoma	132
CanRisk Tool—A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants	90
A Tale of Two Diverse Qualtrics Samples: Information for Online Survey Researchers	87
Sex Differences in Cancer Incidence and Survival: A Pan-Cancer Analysis	81
Neighborhood-Level Redlining and Lending Bias Are Associated with Breast Cancer Mortality in a Large and Diverse Metropolitan Area	79
Type 2 Diabetes and Cancer: An Umbrella Review of Observational and Mendelian Randomization Studies	76
Fusobacterium nucleatum in the Colorectum and Its Association with Cancer Risk and Survival: A Systematic Review and Meta-analysis	69
Modeled Reductions in Late-stage Cancer with a Multi-Cancer Early Detection Test	65
Biomarkers for the Early Detection of Hepatocellular Carcinoma	65
Dietary Intake of Acrylamide and Risk of Breast, Endometrial, and Ovarian Cancers: A Systematic Review and Dose–Response Meta-analysis	64
Radiomics Improves Cancer Screening and Early Detection	63
Assessing Impact of HPV Vaccination on Cervical Cancer Incidence among Women Aged 15–29 Years in the United States, 1999–2017: An Ecologic Study	59
Biomarkers and Strategies for Early Detection of Ovarian Cancer	51
Diversity of Enrollment in Prostate Cancer Clinical Trials: Current Status and Future Directions	50
The Key Characteristics of Carcinogens: Relationship to the Hallmarks of Cancer, Relevant Biomarkers, and Assays to Measure Them	47
The Human Microbiome in Relation to Cancer Risk: A Systematic Review of Epidemiologic Studies	47
Persistent Poverty and Cancer Mortality Rates: An Analysis of County-Level Poverty Designations	46
Cancer Progress and Priorities: Breast Cancer	43
Prevalence of Healthy Behaviors among Cancer Survivors in the United States: How Far Have We Come?	42
Breast Cancer Population Attributable Risk Proportions Associated with Body Mass Index and Breast Density by Race/Ethnicity and Menopausal Status	40
Pediatric Brain Tumors: Descriptive Epidemiology, Risk Factors, and Future Directions	39
Epidemiology and Outcomes of Young-Onset Esophageal Adenocarcinoma: An Analysis from a Population-Based Database	38
A Randomized Comparison of Different Vaginal Self-sampling Devices and Urine for Human Papillomavirus Testing—Predictors 5.1	37
Obstructive Sleep Apnea and Incident Cancer: A Large Retrospective Multicenter Clinical Cohort Study	36

Projected Reductions in Absolute Cancer–Related Deaths from Diagnosing Cancers Before Metastasis, 2006–2015	35
Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose–Response Relationships	34
Neighborhood Social Environmental Factors and Breast Cancer Subtypes among Black Women	33
Diabetes, Glycated Hemoglobin, and Risk of Cancer in the UK Biobank Study	33
Further Guidance in Implementing the Standardized 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Score	33
Head and Neck Cancer Survival Disparities by Race and Rural–Urban Context	33
Black and White Differences in Colorectal Cancer Screening and Screening Outcomes: A Narrative Review	32
Updated Review of Major Cancer Risk Factors and Screening Test Use in the United States in 2018 and 2019, with a Focus on Smoking Cessation	32